Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Dose for Cardiox LFA in Healthy Volunteers
NCT02516319Terminated
- Sponsor
- Cardiox
- Start
- Sep 2012
- Primary completion
- Jan 2016
01
Overview
Open-label trial (2 arms), sponsored by Cardiox. Primary endpoint: ICG dye detection using the LFT system compared to serial blood sampling methods. Started Sep 2012; status: terminated.
Beyond the preview
Go deeper on NCT02516319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516319.